Does Neuromuscular Electrical Stimulation (NMES) Help Relieve Lower Limb Oedema and Improve Joint Mobility and Skin Tissue Oxygenation Levels?
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Oedema
- Sponsor
- National University of Ireland, Galway, Ireland
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Oedema Reduction
- Last Updated
- 11 years ago
Overview
Brief Summary
Neuromuscular Electrical Stimulation (NMES) will be facilitated through the use of a stimulator, with the patient in a semi recumbent position, using UltraStim electrodes. Two 5 cm x 5 cm electrodes will be placed over the soleus muscle for calf stimulation. The participant will be allowed to ramp up the stimulus level themselves to get used to the sensation and determine their maximum tolerated stimulus level.
A goniometer will be used to assess mobility at the knee and ankle joints. Transcutaneous oxygen measurements (tcpO2) will be assessed using the PERIMED Periflux System 500 tcpO2 monitor.
The level of oedema will be measured using the figure of eight measurement, tape circumference measurement and water displacement measurement.
Comfort will also be assessed by use of a 100mm non-hatched visual analogue scale (VAS). Each participant will be asked to indicate their level of comfort following the application of NMES.
Detailed Description
Neuromuscular Electrical Stimulation (NMES) will be facilitated through the use of a two-channel, research stimulator, with the patient in a semi recumbent position, using UltraStim electrodes. Two 5 cm x 5 cm electrodes will be placed over the soleus muscle for calf stimulation. The participant will be allowed to ramp up the stimulus level themselves to get used to the sensation and determine their maximum tolerated stimulus level. A goniometer will be used to assess mobility at the knee and ankle joints. Transcutaneous oxygen measurements (tcpO2) will be assessed using the PERIMED Periflux System 500 tcpO2 monitor. The level of oedema will be measured using the figure of eight measurement, tape circumference measurement and water displacement measurement. Comfort will also be assessed by use of a 100mm non-hatched visual analogue scale (VAS). Each participant will be asked to indicate their level of comfort following the application of NMES. VAS pain scores of 30 mm or less will be categorised as mild pain, between 31 and 69 mm as moderate pain, and scores of 70 mm or greater as severe pain.
Investigators
Gearoid O Laighin
Professor
National University of Ireland, Galway, Ireland
Eligibility Criteria
Inclusion Criteria
- •Patients that present to Merlin Park Podiatry Clinic for Podiatric Intervention who on clinical examination present with lower lib swelling/oedema/
- •Ability to understand the nature of the study.
- •Ability to give informed consent.
Exclusion Criteria
- •Skin ulceration in area of intended electrical stimulation site.
- •Psychiatric disorder.
- •Severe co-morbidity.
- •Patients with uncontrolled heart problems.
- •Patients with pacemakers, DBS.
- •Patients on opioid or neuropathic pain medication.
Outcomes
Primary Outcomes
Oedema Reduction
Time Frame: Approximately three and a half hours
Oedema measurements (figure of eight measurement, tape circumference measurement and water displacement measurement) will be taken before and after the application of neuromuscular electrical stimulation (NMES) in order to assess its affect on the reduction of oedema.
Secondary Outcomes
- Joint Mobility(Approximately three and a half hours)
- Skin Oxygenation(Approximately three and a half hours)